Turbocharge the Development of Best-In-Class Treg-Directed Therapies, Maximizing Stability and Function to Deliver Safe, Scalable and Efficacious Therapies Globally As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies.
17-19 May 2022